| Ambion WT Expression kit |
drug |
3 |
2 |
Ambion® WT Expression Kit, Ambion® WT Expression kit, WT Expression Kit |
| AMD |
phenotype |
2 |
1 |
age-related macular degeneration |
| American adults |
cohort |
7 |
4 |
American adults, American cohort, U.S. adults, adults (ages 18+) |
| American Community Survey |
cohort |
3 |
1 |
ACS |
| American Indians |
cohort |
7 |
3 |
AI, American Indian, American Indian population, Indians of the tribes studied, Native Americans, indigenous people |
| Americans |
cohort |
4 |
1 |
|
| Americas |
cohort |
2 |
1 |
|
| Amerindian |
cohort |
2 |
— |
Amerindian population, Amerindians |
| Amerindian ancestry |
cohort |
2 |
— |
pop4 |
| Ami |
cohort |
2 |
3 |
Amerindian ancestry |
| amino acids |
drug |
4 |
1 |
|
| AML |
phenotype |
5 |
— |
acute myeloid leukemia |
| amlodipine |
drug |
2 |
1 |
|
| ammonia |
drug |
2 |
2 |
peripheral ammonia |
| amnesia |
phenotype |
5 |
2 |
amnesic patients |
| amnestic mild cognitive impairment |
phenotype |
2 |
1 |
MCI, aMCI |
| amount |
phenotype |
2 |
2 |
$5>$0.20 |
| AMP |
drug |
2 |
3 |
amphetamine |
| AMPA |
drug |
3 |
2 |
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor |
| AMPAR |
drug |
4 |
4 |
AMPA, AMPA receptor, AMPA receptors, AMPA type glutamate receptor, AMPAR, AMPARs, GluA1-containing receptors, GluA1A2 heteromers, GluR |
